Mannose receptor‐derived peptides neutralize pore‐forming toxins and reduce inflammation and development of pneumococcal disease
Open Access
- 28 September 2020
- journal article
- research article
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 12 (11)
Abstract
Cholesterol‐dependent cytolysins (CDCs) are essential virulence factors for many human pathogens like Streptococcus pneumoniae (pneumolysin, PLY), Streptococcus pyogenes (streptolysin O, SLO), and Listeria monocytogenes (Listeriolysin, LLO) and induce cytolysis and inflammation. Recently, we identified that pneumococcal PLY interacts with the mannose receptor (MRC‐1) on specific immune cells thereby evoking an anti‐inflammatory response at sublytic doses. Here, we identified the interaction sites between MRC‐1 and CDCs using computational docking. We designed peptides from the CTLD4 domain of MRC‐1 that binds to PLY, SLO, and LLO, respectively. In vitro , the peptides blocked CDC‐induced cytolysis and inflammatory cytokine production by human macrophages. Also, they reduced PLY‐induced damage of the epithelial barrier integrity as well as blocked bacterial invasion into the epithelium in a 3D lung tissue model. Pre‐treatment of human DCs with peptides blocked bacterial uptake via MRC‐1 and reduced intracellular bacterial survival by targeting bacteria to autophagosomes. In order to use the peptides for treatment in vivo , we developed calcium phosphate nanoparticles (CaP NPs) as peptide nanocarriers for intranasal delivery of peptides and enhanced bioactivity. Co‐administration of peptide‐loaded CaP NPs during infection improved survival and bacterial clearance in both zebrafish and mice models of pneumococcal infection. We suggest that MRC‐1 peptides can be employed as adjunctive therapeutics with antibiotics to treat bacterial infections by countering the action of CDCs.Keywords
Funding Information
- Vetenskapsrådet
- The Swedish Foundation for Strategic Research
- Stockholms Läns Landsting
- Knut and Alice Wallenberg Foundations
- National Science Foundation Graduate Research Fellowship Program
- European Research Council (758705)
- Torsten Söderbergs Stiftelse (M87/18)
This publication has 53 references indexed in Scilit:
- Novel Role for the Streptococcus pneumoniae Toxin Pneumolysin in the Assembly of BiofilmsmBio, 2013
- The Cholesterol-Dependent Cytolysin Signature Motif: A Critical Element in the Allosteric Pathway that Couples Membrane Binding to Pore AssemblyPLOS Pathogens, 2012
- A model 450 million years in the making: zebrafish and vertebrate immunityDisease Models & Mechanisms, 2012
- The Pore-Forming Toxin Listeriolysin O Mediates a Novel Entry Pathway of L. monocytogenes into Human HepatocytesPLOS Pathogens, 2011
- Pneumolysin Activates the NLRP3 Inflammasome and Promotes Proinflammatory Cytokines Independently of TLR4PLOS Pathogens, 2010
- Mannose Receptor-Dependent Delay in Phagosome Maturation by Mycobacterium avium GlycopeptidolipidsInfection and Immunity, 2010
- Antibiotics for Emerging PathogensScience, 2009
- Streptococcus pneumoniae evades human dendritic cell surveillance by pneumolysin expressionEMBO Molecular Medicine, 2009
- Pneumolysin Localizes to the Cell Wall of Streptococcus pneumoniaeJournal of Bacteriology, 2009
- Bacterial pore-forming toxins: The (w)hole story?Cellular and Molecular Life Sciences, 2007